loadpatents
Patent applications and USPTO patent grants for Seiwert; Scott D..The latest application filed is for "anti-fibrotic pyridinones".
Patent | Date |
---|---|
Anti-fibrotic pyridinones Grant 10,898,474 - Buckman , et al. January 26, 2 | 2021-01-26 |
Anti-fibrotic pyridinones Grant 10,544,161 - Ramphal , et al. Ja | 2020-01-28 |
Anti-Fibrotic Pyridinones App 20190321343 - Buckman; Brad Owen ;   et al. | 2019-10-24 |
Anti-fibrotic pyridinones Grant 10,376,497 - Buckman , et al. A | 2019-08-13 |
Anti-fibrotic Pyridinones App 20190144467 - Ramphal; Johnnie Y. ;   et al. | 2019-05-16 |
Anti-fibrotic pyridinones Grant 10,233,195 - Ramphal , et al. | 2019-03-19 |
Compounds and methods for treating inflammatory and fibrotic disorders Grant RE47,142 - Kossen , et al. Nov | 2018-11-27 |
Method of modulating stress-activated protein kinase system Grant 10,010,536 - Blatt , et al. July 3, 2 | 2018-07-03 |
Anti-Fibrotic Pyridinones App 20180064692 - Buckman; Brad O. ;   et al. | 2018-03-08 |
Lpa-associated Protein And Rna Expression App 20170314074 - Kossen; Karl ;   et al. | 2017-11-02 |
Anti-fibrotic pyridinones Grant 9,675,593 - Buckman , et al. June 13, 2 | 2017-06-13 |
Anti-fibrotic Pyridinones App 20170121345 - Ramphal; Johnnie Y. ;   et al. | 2017-05-04 |
Method Of Modulating Stress-activated Protein Kinase System App 20170095462 - Blatt; Lawrence M. ;   et al. | 2017-04-06 |
Method of modulating stress-activated protein kinase system Grant 9,527,816 - Blatt , et al. December 27, 2 | 2016-12-27 |
Anti-fibrotic Pyridinones App 20160263090 - Buckman; Brad Owen ;   et al. | 2016-09-15 |
Anti-fibrotic pyridinones Grant 9,359,379 - Buckman , et al. June 7, 2 | 2016-06-07 |
Compounds and methods for treating inflammatory and fibrotic disorders Grant 9,290,450 - Kossen , et al. March 22, 2 | 2016-03-22 |
Anti-fibrotic Pyridinones App 20150266899 - Buckman; Brad Owen ;   et al. | 2015-09-24 |
Lysophosphatidic acid receptor antagonists Grant 8,975,235 - Buckman , et al. March 10, 2 | 2015-03-10 |
Compounds and methods for treating inflammatory and fibrotic disorders Grant 8,969,347 - Kossen , et al. March 3, 2 | 2015-03-03 |
Compounds And Methods For Treating Inflammatory And Fibrotic Disorders App 20140235637 - Kossen; Karl ;   et al. | 2014-08-21 |
Method Of Modulating Stress-activated Protein Kinase System App 20140228310 - Blatt; Lawrence M. ;   et al. | 2014-08-14 |
Lysophosphatidic Acid Receptor Antagonists App 20140213538 - Buckman; Brad Owen ;   et al. | 2014-07-31 |
Lysophosphatidic Acid Receptor Antagonists App 20140200215 - Buckman; Brad Owen ;   et al. | 2014-07-17 |
Method of modulating stress-activated protein kinase system Grant 8,741,936 - Blatt , et al. June 3, 2 | 2014-06-03 |
Anti-fibrotic Pyridinones App 20140107110 - Buckman; Brad Owen ;   et al. | 2014-04-17 |
Anti-fibrotic Pyridinones App 20140094456 - Buckman; Brad Owen ;   et al. | 2014-04-03 |
Methods Of Diagnosing And Treating Idiopathic Pulmonary Fibrosis App 20130150426 - KOSSEN; KARL ;   et al. | 2013-06-13 |
Compounds And Methods For Treating Inflammatory And Fibrotic Disorders App 20130102597 - Kossen; Karl ;   et al. | 2013-04-25 |
Lysophosphatidic Acid Receptor Antagonists App 20130072449 - Buckman; Brad O. ;   et al. | 2013-03-21 |
Compounds and methods for treating inflammatory and fibrotic disorders Grant 8,304,413 - Kossen , et al. November 6, 2 | 2012-11-06 |
Macrocyclic inhibitors of hepatitis C virus replication Grant 8,299,021 - Blatt , et al. October 30, 2 | 2012-10-30 |
Method Of Modulating Stress-activated Protein Kinase System App 20120258924 - Blatt; Lawrence M. ;   et al. | 2012-10-11 |
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20120251493 - Seiwert; Scott D. ;   et al. | 2012-10-04 |
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20120208995 - Blatt; Lawrence M. ;   et al. | 2012-08-16 |
Substituted Proline Inhibitors Of Hepatitis C Virus Replication App 20120095211 - Buckman; Brad ;   et al. | 2012-04-19 |
Novel Inhibitors Of Hepatitis C Virus Replication App 20120094897 - Buckman; Brad ;   et al. | 2012-04-19 |
Methods Of Treating Atrial Fibrillation With P38 Inhibitor Compounds App 20120046321 - Olgin; Jeff ;   et al. | 2012-02-23 |
Compounds and methods for inhibiting hepatitis C viral replication Grant 8,119,592 - Beigelman , et al. February 21, 2 | 2012-02-21 |
Novel Inhibitors Of Hepatitis C Virus Replication App 20110312996 - Buckman; Brad ;   et al. | 2011-12-22 |
Macrocyclic inhibitors of hepatitis C virus replication Grant 8,048,862 - Seiwert , et al. November 1, 2 | 2011-11-01 |
Use of Alpha-Glucosidase Inhibitors to Treat Alphavirus Infections App 20110177026 - Blatt; Lawrence M. ;   et al. | 2011-07-21 |
Novel Inhibitors Of Hepatitis C Virus Replication App 20110152246 - Buckman; Brad ;   et al. | 2011-06-23 |
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20110059047 - Seiwert; Scott D. ;   et al. | 2011-03-10 |
Method of Modulating Stress-Activated Protein Kinase System App 20110034495 - Seiwert; Scott D. ;   et al. | 2011-02-10 |
Hyperglycosylated Polypeptide Variants And Methods Of Use App 20110008289 - BLATT; LAWRENCE M. ;   et al. | 2011-01-13 |
Macrocyclic inhibitors of hepatitis C virus replication Grant 7,829,665 - Blatt , et al. November 9, 2 | 2010-11-09 |
Method Of Modulating Stress-activated Protein Kinase System App 20100240704 - Blatt; Lawrence M. ;   et al. | 2010-09-23 |
Method of modulating stress-activated protein kinase system Grant 7,728,013 - Blatt , et al. June 1, 2 | 2010-06-01 |
Synthetic Hyperglycosylated, Protease-resistant Polypeptide Variants, Oral Formulations And Methods Of Using The Same App 20100099851 - Hong; Jin ;   et al. | 2010-04-22 |
Methods of Treating Atrial Fibrillation with P38 Inhibitor Compounds App 20100029578 - Olgin; Jeff ;   et al. | 2010-02-04 |
Compounds And Methods For Treating Inflammatory And Fibrotic Disorders App 20090318455 - Kossen; Karl ;   et al. | 2009-12-24 |
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20090269305 - Seiwert; Scott D. ;   et al. | 2009-10-29 |
Hyperglycosylated polypeptide variants and methods of use Grant 7,597,884 - Blatt , et al. October 6, 2 | 2009-10-06 |
Novel Macrocyclic Inhibitors Of Hepatitis C Virus Replication App 20090169510 - Blatt; Lawrence M ;   et al. | 2009-07-02 |
Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication App 20090148407 - Blatt; Lawrence M. ;   et al. | 2009-06-11 |
Compounds And Methods For Inhibiting Hepatitis C Viral Replication App 20090093533 - Beigelman; Leonid ;   et al. | 2009-04-09 |
Novel Inhibitors Of Hepatitis C Virus Replication App 20090047246 - Beigelman; Leonid ;   et al. | 2009-02-19 |
Use of pirfenidone in therapeutic regimens Grant 7,407,973 - Ozes , et al. August 5, 2 | 2008-08-05 |
Use of pirfenidone in therapeutic regimens App 20070117841 - Ozes; Osman N. ;   et al. | 2007-05-24 |
Novel macrocyclic inhibitors of hepatitis C virus replication App 20070054842 - Blatt; Lawrence M. ;   et al. | 2007-03-08 |
Use of alpha-glucosidase inhibitors to treat alphavirus infections App 20060269517 - Blatt; Lawremce M. ;   et al. | 2006-11-30 |
Method of modulating stress-activated protein kinase system App 20060270612 - Blatt; Lawrence M. ;   et al. | 2006-11-30 |
Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same App 20060204473 - Blatt; Lawrence M. ;   et al. | 2006-09-14 |
Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same App 20060182716 - Hong; Jin ;   et al. | 2006-08-17 |
Interferon compositions and methods of use thereof App 20060018875 - Blatt; Lawrence M. ;   et al. | 2006-01-26 |
NCAGE Code | 47KJ3 | SEIWERT SCOTT D |
CAGE Code | 47KJ3 | SEIWERT, SCOTT D |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.